Study pairs anti-DgcE antibody with gentamicin against APEC

A new laboratory study reports that an IgM monoclonal antibody, called E11G12, can make gentamicin work better against avian pathogenic Escherichia coli by targeting the bacterial diguanylate cyclase DgcE and disrupting c-di-GMP signaling. According to the study abstract, that combination increased intracellular antibiotic accumulation and produced a synergistic antibacterial effect against APEC, a major cause of colibacillosis in poultry. The work is early-stage and appears to position DgcE, a regulator tied to biofilm-associated behavior, as a possible antivirulence or antibiotic-potentiating target rather than a stand-alone replacement for conventional antimicrobials. APEC remains a significant poultry pathogen, and prior reviews have described it as a major cause of morbidity, mortality, and production loss, with biofilm formation and antimicrobial resistance complicating control efforts. (mdpi.com)

Why it matters: For veterinary professionals, especially those working in poultry health, the study adds to a broader search for ways to restore activity of existing antibiotics instead of relying only on new drug classes. That matters because APEC isolates have shown substantial multidrug resistance, including reported gentamicin resistance in historical and more recent surveillance literature, and biofilm biology is one reason treatment can be difficult. If the antibody’s effect holds up in animal studies, it could point toward combination approaches that lower effective antibiotic exposure, improve response in hard-to-treat infections, or support antimicrobial stewardship in food-animal medicine. Still, this is a research finding, not a clinical product, and there’s no indication yet of regulatory review or field-ready use. (pubmed.ncbi.nlm.nih.gov)

What to watch: The next key step is whether the antibody-gentamicin combination moves from in vitro results into poultry challenge studies, safety work, and eventually a practical delivery and regulatory pathway for use in flocks. (fda.gov)

Read the full analysis →

Like what you're reading?

The Feed delivers veterinary news every weekday.